The consumption of CravingZ’Gone® not only results in a significant reduction in the desire to eat but also impacts other appetite feelings such as hunger, prospective consumption (which are significantly decreased after a calibrated breakfast and an ad libitum lunch), satiety and fullness (which are significantly increased).
Food intake during an ad libitum lunch is significantly reduced after consuming CravingZ’Gone® for 14 days.
After 14 days of CravingZ’Gone® consumption, and without intervention on lifestyle, body weight and fat mass (but not lean mass) are significantly decreased in overweight subjects.
The promising results from this short-term clinical study obtained in overweight subjects without eating restriction suggest that CravingZ’Gone® would be helpful to enhance the compliance of hypocaloric diets.
After consumption, CravingZ’Gone® reaches the large intestine where it is fermented by the intestinal microbiota. This fermentation results in the production of short chain fatty acids (SCFA), which further modulate the release of stomach and gut hormones involved in hunger and satiety, such as ghrelin, GLP-1 and PYY. These hormones travel to the the brain, resulting in the regulation of appetite and eventually energy intake.
CravingZ’Gone® consumption significantly reduces plasmatic ghrelin, a hunger-stimulating hormone, in both fasting and post-prandial states.